HIGHLIGHTS
- who: Giusi Barra et al. from the Stockholm University, Sweden Tongji University, China have published the research work: The immunoregulatory effect of the TREM2-agonist Sulfavant A in human allogeneic mixed lymphocyte reaction, in the Journal: (JOURNAL)
- what: The authors investigate the effect of SULF A in an experimental model of allogeneic MLR with MoDCs isolated from a human donor that were co-cultured with nau00efve T_cells of another individual at 1:10 ratio. The authors showed that SULF A can modulate Frontiers in Immunology frontiersin.org 10.3389/fimmu.2023.1050113 synapse by expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.